| 前收市價 | 0.1100 |
| 開市 | 0.1100 |
| 買盤 | 0.0000 |
| 賣出價 | 0.7500 |
| 拍板 | 12.50 |
| 到期日 | 2024-05-17 |
| 今日波幅 | 0.1100 - 0.1100 |
| 合同範圍 | 無 |
| 成交量 | |
| 未平倉合約 | 14 |
ZacksFate Therapeutics (FATE) Reports Q1 Loss, Tops Revenue Estimates
Fate Therapeutics (FATE) delivered earnings and revenue surprises of 0% and 140.63%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
ZacksFate Therapeutics (FATE) Surges 86.4% YTD on Pipeline Progress
Fate Therapeutics (FATE) gains 86.4% on encouraging pipeline progress of its cellular immunotherapies for cancer.
ZacksWhy Is Amicus Therapeutics (FOLD) Down 8.1% Since Last Earnings Report?
Amicus Therapeutics (FOLD) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
